baber/WOPTO huggingface dataset:
Patent JP-3712130-B2 (JP)
IPC: A23L13/40
Filed: 1995-09-20
Granted: 2005-11-02
Abstract: PCT No. PCT/DK95/00375 Sec. 371 Date Mar. 6, 1997 Sec. 102(e) Date Mar. 6, 1997 PCT Filed Sep. 20, 1995 PCT Pub. No. WO96/08974 PCT Pub. Date Mar. 28, 1996A method for treating an aqueous protein solution so as to kill microorganisms which may be present therein, but without causing coagulation, comprises either (1) mixing the solution with sufficient enzymatically produced protein hydrolysate (H1) to prevent coagulation of the mixture when the mixture is subsequently subjected to a heat treatment to kill microorganisms, and then subjecting the mixture to such a heat treatment, or (2) using one or more enzymes to hydrolyze protein in the aqueous protein solution to an extent sufficient to prevent coagulation of the resulting liquid hydrolysate (H2) when it is subsequently subjected to a heat treatment to kill microorganisms, and then subjecting the liquid hydrolysate (H2) to such a heat treatment. The use of aqueous protein solutions treated in this manner in the production of a foodstuff, such as a meat-based foodstuff, contributes very significantly to reducing any risk of contamination of the foodstuff by harmful microorganisms.
Patent JP-2537726-B2 (JP)
IPC: A61M39/00
Filed: 1991-05-03
Granted: 1996-09-25
Abstract: A tubular adaptor releasably interconnects an IV conventional catheter hub to fluid supply tubing. A latching clip slidably mounted on the adaptor cooperates with flange portions on the catheter hub to secure the interconnection between the hub and the adaptor. The adaptor is snapped into a base attached to the patient's skin by an adhesive pad. After the catheter connection is made, the adaptor, together with the clip, is rotated about 90 DEG  on the base into a low profile position, wherein the clip is close to the patient's skin.
Patent JP-3174337-B2 (JP)
IPC: C08F2/46
Filed: 1992-12-11
Granted: 2001-06-11
Abstract: Disclosed are radiation-crosslinkable elastomeric compositions containing: (a) an elastomeric polymer containing abstractable hydrogen atoms in an amount sufficient to enable the elastomeric polymer to undergo crosslinking in the presence of a suitable radiation-activatable crosslinking agent; and (b) a radiation-activatable crosslinking agent of the formula:   <IMAGE>   wherein: W represents -O-, -N-, or -S-; X represents CH3- or   <IMAGE>   Y represents a ketone, ester, or amide functionality; Z represents an organic spacer which does not contain hydrogen atoms that are more photoabstractable than hydrogen atoms of the elastomeric polymer; m represents an integer of 0 to 6; a represents 0 or 1; and n represents an integer of 2 or greater. Radiation-crosslinked elastomers are prepared by exposing the radiation-crosslinkable elastomeric compositions to radiation (e.g., UV light) to abstract hydrogen atoms from the elastomeric polymer by the resulting radiation-activated crosslinking agent.
Patent JP-3350049-B2 (JP)
IPC: A61K51/00
Filed: 1991-08-09
Granted: 2002-11-25
Abstract: PCT No. PCT/US91/05553 Sec. 371 Date Mar. 23, 1993 Sec. 102(e) Date Mar. 23, 1993 PCT Filed Aug. 9, 1991 PCT Pub. No. WO92/02260 PCT Pub. Date Feb. 20, 1992.3 beta -[4-iodophenyl]-tropan-2 beta -carboxylic acid methyl ester tartrate is a high affinity binding ligand for cocaine receptors in mammalian brains. It and its congeners may be employed for imaging and other brain scanning techniques that allow the determination of the presence of cocaine receptors, such as dopamine and serotonin transporters and the like.
Patent JP-3646142-B2 (JP)
IPC: G11B5/02
Filed: 1997-09-29
Granted: 2005-05-11
Abstract: A magnetic marker or tag is disclosed which comprises (a) a first magnetic material characterised by high permeability, low coercivity and a non-linear B-H characteristic; and (b) a second magnetic material which is capable of being permanently magnetised, said first and second magnetic materials being superimposed one on the other and advantageously being substantially coterminous. The second magnetic material is preferably of medium coercivity. Selected regions of said second magnetic material can carry magnetisation such as to magnetically divide the first magnetic material into a series of magnetically discrete zones, the length of said magnetically discrete zones and/or the lengths of said magnetised regions ("gaps") of said second material constituting elements of a code.
Patent JP-3921552-B2 (JP)
IPC: A61K39/00
Filed: 1997-10-29
Granted: 2007-05-30
Abstract: The invention comprises a method for generating an infectious clone based on the genome of a positive strand RNA virus which has a genome of at least about 15 kb. The invention further comprises a method for generating an infectious clone based on the genome of an RNA virus, said method further comprising selecting infectious clones by transfecting a host cell with said recombinant nucleic acid whereby said host cell is in essence not susceptible to infection with said virus. The invention further provides modified RNA viruses and vaccines and diagnostic assays derived thereof.
Patent JP-4004070-B2 (JP)
IPC: A61K39/395
Filed: 1997-11-17
Granted: 2007-11-07
Abstract: Combined use of a compound of formula I <CHEM>  wherein   R1   is an optionally substituted straight- or branched carbon chain having 12 to 22 carbon atoms which may be optionally interrupted by an optionally substituted phenylene, and  each of R2, R3, R4 and R5, independently, is H or lower alkyl, in free form or in pharmaceutically acceptable salt form,
Patent JP-3626184-B2 (JP)
IPC: A61K9/107
Filed: 1994-05-16
Granted: 2005-03-02
Abstract: PCT No. PCT/US94/05589 Sec. 371 Date Nov. 16, 1995 Sec. 102(e) Date Nov. 16, 1995 PCT Filed May 18, 1994 PCT Pub. No. WO94/26255 PCT Pub. Date Nov. 24, 1994The present invention provides pharmaceutical vaccine compositions that are nanoemulsions of particles having a lipid core which is in a solid or liquid crystalline phase at 25 DEG  C., and which is surrounded by at least one phospholipid bilayer for the parenteral, oral, intranasal, rectal, vaginal or topical delivery of both hydrophilic and lipophilic immunogens. The particles have a mean diameter in the range of 10 to 250 nm and the immunogen is incorporated therein, either intrinsically prior to the homogenization process or extrinsically thereafter.
Patent JP-4020967-B2 (JP)
IPC: H04J13/00
Filed: 1997-02-04
Granted: 2007-12-12
Abstract: The method involves a radio system which receives an RF analogous signal at RF sections, from an antenna (10), for IF transfer and filtering. This is then input to an A/D converter and then a demodulator for restoring a broadband, spread-coded pseudo-noise signal to a narrowband data signal using an incoherent demodulator. An orthogonal demodulator determines the bits of the received data signal. A signal noise estimate is formed (14) and a selector, selects the base station transceiver unit candidates with the best connections for a future connection. The channel decoder (16) decodes a convolution-coded signal based on a Viterbi algorithm and a source decoder (17) decodes a residually excited linear predictive signal from the channel decoder for a loudspeaker.
Patent JP-4129994-B2 (JP)
IPC: A61P35/00
Filed: 1997-03-24
Granted: 2008-08-06
Abstract: There is provided an inhibitor of angiogenesis induced by growth of the vascular endothelial cells that comprises Tissue Factor Pathway Inhibitor (TFPI) as an active ingredient. The TFPI-containing preparation of the present invention can effectively inhibit angiogenesis induced by growth of the vascular endothelial cells, and thus, is quite efficacious for preventing and treating the conditions of diseases associated with angiogenesis such as malignant tumors. <IMAGE>
Patent JP-3352095-B2 (JP)
IPC: A61K31/55
Filed: 1998-02-23
Granted: 2002-12-03
Abstract: Nifedipine, optionally in combination with bethanechol, is administered locally to the anus for the treatment of benign anal disorders, in particular anal fissures and haemorrhoids. The agents induce a reduction in the mean and resting pressure, thereby assisting in the healing of anal fissures and haemorrhoids. Optionally, the active agents may be co-administered with a steroid, such as hydrocortisone.
Patent JP-4531132-B2 (JP)
IPC: A61P35/00
Filed: 1996-05-30
Granted: 2010-08-25
Abstract: Methods are described for the identification and preparation of high-affinity nucleic acid ligands to TGF², PDGF and hKGF. Included in the invention are specific RNA and ssDNA ligands to TGF²1 and PDGF identified by the SELEX method. Also included in the invention are specific RNA ligands to hKGF identified by the SELEX method. Further included are RNA ligands that inhibit the interaction of TGF²1 and hKGF with their receptors and DNA ligands that inhibit the interaction of PDGF with its receptor.
Patent ES-2257900-B2 (ES)
Title: Contenedor de recogida de polvo para una aspiradora.
Inventor: LEE HYUN-JU
IPC: A47L9/20
Filed: 2003-08-05
Granted: 2007-04-01
Abstract: Contenedor de recogida de polvo para una aspiradora, que se encuentra montado en una cámara de succión del cuerpo de una aspiradora para filtrar el polvo del aire cargado de polvo que es aspirado en la cámara de succión á través de un agujero de succión de aire que está conectado con el exterior. El contenedor de recogida de polvo tiene una carcasa de recogida de polvo que tiene un agujero de conexión conectado con el agujero de succión de aire y una parte de descarga para descargar el aire aspirado, y un conjunto de filtro que tiene al menos tres filtros, y montado en forma desmontable en la parte de descarga. Con la pluralidad de filtros que filtran respectivamente y en forma secuencial desde las partículas más grandes hasta las más pequeñas del aire cargado de polvo aspirado en la cámara de recogida de polvo, el contenedor de recogida de polvo se bloquea raramente incluso durante un periodo largo de uso.
Patent AU-2001240073-B2 (AU)
Title: Device for cushioning of compression surfaces in mammograph
Inventor: WILLIS DAVID
IPC: A61B6/04
Filed: 2001-03-06
Granted: 2005-07-21
Abstract: Apparatus are provided for providing cushioning on devices requiring the patient or tissue to be compressed, such as radiography machines, fluoroscopy units, mammography units and the like. In particular a radiolucent pad element is provided for releasable attachment to at least one surface of a compression device to be used under x-ray, for example, during mammography. The pad element of the present application can be disposable or constructed to be reusable and in some cases may be applied directly to the patient's breast. Furthermore, a cushioned compression paddle or x-ray plate is provided wherein said compression paddle or x-ray plate and said cushion can be separately or integrally formed.
Patent AU-2001241146-B2 (AU)
Title: Glucopyranosyloxy benzylbenzene derivatives, medicinal compositions containing the same and intermediates for the preparation of the derivatives
Inventor: TOKUTAKE YOSHIKI
IPC: C07C69/18
Filed: 2001-03-15
Granted: 2006-06-29
Abstract: The present invention relates to glucopyranosyloxybenzylbenzene derivatives represented by the general formula: <CHEM> wherein R<1> represents a hydrogen atom or a hydroxy( lower alkyl) group; and R<2> represents a lower alkyl group, a lower alkoxy group, a lower alkylthio group, a hydroxy(lower alkyl) group, a hydroxy(lower alkoxy) group, a hydroxy(lower alkylthio) group etc., and salts thereof, which have an excellent inhibitory activity in human SGLT2 and are useful as agents for the prevention or treatment of diabetes, obesity etc., and intermediates thereof.
Patent AU-2001275019-B2 (AU)
Title: Medicament-loaded transdermal reservoir and method for its formation
Inventor: O'GRADY DANIEL
IPC: A61K47/18
Filed: 2001-05-30
Granted: 2005-09-15
Abstract: A method for preparing a charged reservoir-electrode unit comprises a first reservoir-electrode disposed to operate as an anode (60) and a second reservoir-electrode disposed to operate as a cathode (62). <??>An iontophoresis reservoir-electrode comprises a backing (12), a bibulous reservoir (18) and a removable closure (24) having an absorbent material. <IMAGE> <IMAGE> <IMAGE> <IMAGE> <IMAGE> <IMAGE> <IMAGE>
Patent AU-2002310785-B2 (AU)
Title: Porous sponge-like cellulosic material for treatment of injuries
Inventor: VILJANTO JOUKO
IPC: A61K33/34
Filed: 2002-06-11
Granted: 2006-10-19
Abstract: The invention comprises a porous sponge-like cellulosic material to be used in treatment of injuries and/or burns. The cellulosic material comprises zinc, copper, selenium and/or iron bound to and/or absorbed into the material matrix in amounts sufficient to support wound base granulation and revascularisation, the amount of zinc, copper, selenium and iron being at least 0.1 mug/g dry material.
Patent AU-2002319922-B2 (AU)
Title: Positively charged amphiphilic block copolymer as drug carrier and complex thereof with negatively charged drug
Inventor: CHOI IN-JA
IPC: A61K31/196
Filed: 2002-07-13
Granted: 2004-12-16
Abstract: The present invention provides a cationic group-containing amphiphilic block copolymer that is biocompatible and biodegradable, and when used as a drug carrier for an anionic drug, provides several advantages, such as increased blood concentration and improved stability of the drug.
Patent AU-2002335492-B2 (AU)
Title: Polynucleotide useful for modulating cancer cell proliferation
Inventor: FERRER JOSE-ANTONIO CAMARA Y
IPC: C07K16/32
Filed: 2002-03-01
Granted: 2006-11-02
Abstract: The invention concerns a novel protein modulating cancer cell proliferation. The proteins encoded by the polynucleotides of the invention enable to determine the degree of malignity of abnormal cell proliferation.
Patent AU-2002352452-B2 (AU)
Title: Glassware corrosion inhibitor
Inventor: HAHN KARLHEINZ ULRICH GERHARD
IPC: C11D3/12
Filed: 2002-12-19
Granted: 2007-06-21
Abstract: Article for use in a dishwashing machine, which comprises a water-soluble glass or ceramic composition effective to reduce corrosion of glassware and at least one surfactant containing composition, wherein the amount of the glass or ceramic composition is within the range of 5 to 95 wt. % and the amount of the surfactant is in the range of 5 to 95 wt. %, both percentages based on the weight of the article.
Patent AU-2003244544-B2 (AU)
Title: Antibiotic Polymer Combination/antibiotics Polymer Combination
Inventor: KUHN KLAUS-DIETER
IPC: A61L27/54
Filed: 2003-09-03
Granted: 2005-08-04
Abstract: A composite (A) comprises: (1) a homogeneous mixture (A1) of at least one hydrophobic, nonionic polymer (I) and at least one hydrophilic polyether (II); and (2) at least one antibiotic salt (III) that is sparingly soluble in water. A composite (A) comprises: (1) a homogeneous mixture (A1) of at least one hydrophobic, nonionic polymer (I) and at least one hydrophilic polyether (II); and (2) at least one antibiotic salt (III) that is sparingly soluble in water. (I) is PVC, optionally post-chlorinated; poly(vinylidene chloride or fluoride), poly(vinyl fluoride) or a copolymer of vinyl chloride with at least one nonionic monomer. (III) is the salt of an aminoglycoside, lincosamide, tetracycline, glycopeptide or quinolone antibiotic, or of chlorhexidine. (A) may also include (i) an antibiotic (IV; aminoglycoside, lincosamide, beta-lactam or tetracycline) that is freely soluble in water and (ii) one or more organic auxiliaries.
Patent AU-2004250256-B2 (AU)
Title: Assay and kits for detecting protein binding
Inventor: TREIVER DANIEL KELLY
IPC: C12Q/
Filed: 2004-06-21
Granted: 2010-03-25
Abstract: The invention provides methods for determining the interactions between phage-displayed proteins and test molecules. The phage-displayed proteins are contacted with a reference moiety in the presence and absence of a test molecule; the behavior of the phage-displayed proteins as a function of concentration of the test molecule permits calculation of the binding affinity of the phage-displayed protein for the test molecule.
Patent AU-2004256976-B2 (AU)
Title: Human antibody molecules for IL-13
Inventor: SHORROCK CELIA PATRICIA
IPC: C07K16/24
Filed: 2004-07-15
Granted: 2010-12-23
Abstract: There are described recombinant VH and VL domains of human antibodies that bind IL-13. A series of proteins characterised by three CDR in each VH/VL are described. Preferably the molecules are single chain Fv or antibody molecules. Nucleic acids expressing the VH and VL domains are selected from phage display libraries. Neutralization potency of the resulting scFv's was tested in TF proliferation assays. The fragments and antibodies showed efficacy for IL-13 binding in murine models of pulmonary inflammation, the primate (cynomolgus) model of dermal allergy, IgE release from B cells and histamine potentiation in Ca2+ signalling in smooth muscle. Mice transgenic for human IL-13 antibodies and epitope mapping studies are also described. It is envisaged that the anti 11-13 reagents may be used to treat asthma, atopic dermatitis, allergic rhinitis, fibrosis, IBS, or Hodgkin's lymphoma.
Patent AU-2005201776-B2 (AU)
Title: An intervertebral disk implant
Inventor: HELLER MATHIAS
IPC: B29C45/14
Filed: 2005-04-28
Granted: 2007-04-19
Abstract: The implant is assembled of two outer shells (115, 117) to be inserted between the prepared vertebrae and the inner core (119) accommodated between them. The core (119) is of a lens shape and has two articulation areas (149) differing from the complementary areas (147) located at the inner surfaces of the outer shells. The areas positioned at the core surface (149) can be designed with a more intense curvature optimizing the shock absorbing quality of the core (119) which can be assembled of two parts and/or fitted with a supporting cushion.
Patent AU-2005284131-B2 (AU)
Title: Substituted bicyclic imidazo-3-YL-amine compounds
Inventor: THOMAS TZSCHENTKE
IPC: A61K31/4188
Filed: 2005-09-08
Granted: 2011-07-14
Abstract: The invention relates to substituted bicyclic imidazo-3-ylamine compounds of general formula (I), methods for production, medicaments containing the same and use thereof for the production of medicaments.
Patent AU-2005318171-B2 (AU)
Title: Binding molecules capable of neutralizing West Nile virus and uses thereof
Inventor: MARK THROSBY
IPC: A61K51/10
Filed: 2005-12-19
Granted: 2011-09-29
Abstract: The present invention provides human binding molecules specifically binding to West Nile virus and having West Nile virus neutralizing activity, nucleic acid molecules encoding the human binding molecules, compositions comprising the human binding molecules and methods of identifying or producing the human binding molecules. The human binding molecules can be used in the diagnosis, post-exposure prophylaxis and/or treatment of a condition resulting from West Nile virus.
Patent AU-2006234767-B2 (AU)
Title: High frequency signal hub and transmission system
Inventor: MONSEN VAVIK GEIR
IPC: H04B10/29
Filed: 2006-04-11
Granted: 2011-07-07
Abstract: The present invention concerns signal repeater system solutions of the general type.
Patent AU-2006268856-B2 (AU)
Title: Tool for machining boreholes
Inventor: HABERLE FRIEDRICH
IPC: B23B27/14
Filed: 2006-07-13
Granted: 2011-01-20
Abstract: A tool for machining borehole surfaces, includes a base body, a cutting device having at least one cutting die with at least one geometrically defined tool edge, and at least one guide surface for guiding the tool (1) inside the machined borehole. The at least one cutting die being tangentially fastened to the end face of the tool, and preferably embedded therein, The at least one cutting die is provided with a rounded cut for producing a support surface adjacent to the tool edge is produced, the support surface being arched with a radius that is smaller than the radius of the borehole to be machined, and the region of the support surface directly adjoining the tool edge resting against the borehole wall to be machined, and the end region of the support surface, as viewed in the peripheral direction of the tool, which is situated at a distance from the tool edge being situated at a distance from the wall of the borehole.
Patent AU-2006297004-B2 (AU)
Title: Bi-component synthetic fibres for application in cement-bonded building materials
Inventor: EUGEN SCHWITTER
IPC: E04C5/07
Filed: 2006-09-21
Granted: 2011-11-24
Abstract: The core/shell fibre is made from plastics such as polypropylene, polyethylene or a mixture of said raw materials or other thermoplastic polymers. The fibre diameter is 0.15 to 2.0 mm and the core/shell fibre has a completely- or intermittently-structured surface, generated by embossing (5) which is carried out on a single side or multiple sides, the depth of which is at least 10 % of the average fibre diameter. The embossing (5) can be perpendicular or diagonal or in any form with relation to the fibre direction, but in any case is increased by a factor of 5 to 15 after drawing the fibre. The core/shell fibre is cut in sections of 10 to 80mm and collected in bundles of several thousand and wound in a water-soluble plastic film. Said fibres are used to increase the tensile strength, to improve the crush resistance or generally for mechanical reinforcement of cement-bonded building materials, in particular in concrete. The bundles can be incorporated together with the plastic film in the building material with no disadvantages.
Patent AU-2006340804-B2 (AU)
Title: Secure bag assembly for a lockable removable cassette
Inventor: CLAUSER ROBERT J
IPC: B65H1/00
Filed: 2006-12-27
Granted: 2012-01-12
Abstract: A method and apparatus are provided relating to a secure bag assembly to secure cash in transit ("CIT"). In some implementations, the secure bag assembly is installed in a lockable, removable cassette that is fitted to a bill validator. The casset and bill validator can be installed in an enclosure like those found in retail kiosks, self-checkout terminals, retail safes or gaming machines. In such an implementation bank notes are deposited in the bill validator and once identified and validated, are securely stacked in the bag assembly within the cassette. The bag assembly can be used for capacities of one banknote up to the maximum capacity allowed by the cassette. The bag assembly is secured in place when installed and is sealed automatically upon removal from the cassette.
Patent AU-2007222909-B2 (AU)
Title: Anode for cathodic protection
Inventor: WHITMORE DAVID
IPC: C23F13/16
Filed: 2007-02-21
Granted: 2012-05-03
Abstract: An anode for use in cathodic protection of steel in concrete is formed from an electrically conductive material such as zinc and an ionically conductive material which is preferably a humectant and/or has a pH greater than 12 to enhance current flow. The materials are intimately intermixed through at least a part of the anode body and compressed into the anode body with an electrical connecting lead formed into a core of the body which is wholly conductive material. Portions of the electrically conductive material are pressed into electrical contact to form a plurality of electrically conductive paths within the anode body. Many of the voids in the body are interconnected to form a plurality of ionically conductive paths through the anode body by causing the humectant to migrate through the voids. The large surface area between the ionically conductive paths and the electrically conductive paths increase significantly the contact surface area of the anode body to increase current flow.